中外医疗
中外醫療
중외의료
CHINA FOREIGN MEDICAL TREATMENT
2014年
20期
172-173
,共2页
临床路径%儿童肺炎%经济学
臨床路徑%兒童肺炎%經濟學
림상로경%인동폐염%경제학
Clinical pathway%Children pneumonia%Economics
目的:评价临床路径(CPN)标准化诊疗对儿童肺炎患者费用的影响,指导儿童肺炎临床路径的管理。方法采用回顾性的方法,对实验组430例临床路径管理标准化治疗的肺炎患儿与对照组417例传统治疗的肺炎患儿就其住院天数、药费、总费用、药占比等运用统计学方法进行分析评价。结果实验组相比对照组在药品费用方面平均减少395元(P<0.05),而在治疗总费用方面平均减少561元(P<0.05),此两项差异有统计学意义。在住院天数、药占比两项方面,差异无统计学意义(P>0.05),。结论在不影响肺炎患儿治疗的同时,临床路径的实施有利于降低患儿的诊疗费用,从时间、经济、疗效上改善患儿病情。
目的:評價臨床路徑(CPN)標準化診療對兒童肺炎患者費用的影響,指導兒童肺炎臨床路徑的管理。方法採用迴顧性的方法,對實驗組430例臨床路徑管理標準化治療的肺炎患兒與對照組417例傳統治療的肺炎患兒就其住院天數、藥費、總費用、藥佔比等運用統計學方法進行分析評價。結果實驗組相比對照組在藥品費用方麵平均減少395元(P<0.05),而在治療總費用方麵平均減少561元(P<0.05),此兩項差異有統計學意義。在住院天數、藥佔比兩項方麵,差異無統計學意義(P>0.05),。結論在不影響肺炎患兒治療的同時,臨床路徑的實施有利于降低患兒的診療費用,從時間、經濟、療效上改善患兒病情。
목적:평개림상로경(CPN)표준화진료대인동폐염환자비용적영향,지도인동폐염림상로경적관리。방법채용회고성적방법,대실험조430례림상로경관리표준화치료적폐염환인여대조조417례전통치료적폐염환인취기주원천수、약비、총비용、약점비등운용통계학방법진행분석평개。결과실험조상비대조조재약품비용방면평균감소395원(P<0.05),이재치료총비용방면평균감소561원(P<0.05),차량항차이유통계학의의。재주원천수、약점비량항방면,차이무통계학의의(P>0.05),。결론재불영향폐염환인치료적동시,림상로경적실시유리우강저환인적진료비용,종시간、경제、료효상개선환인병정。
Objective To evaluate the effect of standardized diagnosis and treatment of clinical pathway on the cost of children pneumonia so as to guide the management of children pneumonia clinical pathway. Methods A retrospective method combined with statistical method was used to analyze and evaluate the length of stay, expenses for medicine, the total cost, drug proportion and so on of the experimental group (430 cases) treated by standard management treatment of clinical pathway and the control group treated by traditional treatment (417 cases). Results The drug cost of the experimental group was reduced by an average of 395 yuan (P<0.05) compared with that of the control group, and total cost in the treatment was reduced by an average of 561 yuan (P<0.05), the differences were statistical significant. In the days of hospitalization, drug proportion, the differences between the two groups were not statistically significant (P>0.05). Conclusion The implementation of clinical pathway can reduce the medical ex-penses of children, and improve the disease of the children from the aspect of time, economy and efficacy without affecting the treatment of children with pneumonia.